VirtaMed AG, headquartered in Switzerland (CH), is a pioneering company in the medical simulation industry, specialising in advanced training solutions for healthcare professionals. Founded in 2009, VirtaMed has established itself as a leader in the development of high-fidelity simulators that enhance the learning experience in various medical fields, including surgery and obstetrics. The company’s core products, such as the VirtaMed LaparoS and VirtaMed HystSim, utilise cutting-edge technology to provide realistic, immersive training environments. These simulators are distinguished by their ability to replicate complex clinical scenarios, allowing practitioners to hone their skills without risk to patients. With a strong presence in Europe and expanding operations globally, VirtaMed AG continues to set benchmarks in medical education, contributing significantly to improved patient outcomes and safety in healthcare.
How does VirtaMed AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
VirtaMed AG's score of 21 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
VirtaMed AG, headquartered in Switzerland (CH), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available from the company. This lack of data suggests that VirtaMed AG may not have established formal commitments to reduce carbon emissions or may not publicly disclose such information at this time. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how VirtaMed AG aligns with these industry standards. As the company progresses, it may consider implementing measurable climate strategies to enhance transparency and contribute to global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
VirtaMed AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
